The different approaches currently targeted for treatment are suppression of liver gluconeogenesis, restoration of beta cell mass, incretin action, enhancement of insulin production, insulin supplementation, reduction in obesity, reduction in plasma free fatty acid levels, normalizing plasma glucose, reducing oxidative stress and exercise. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.